^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LP002

    i
    Other names: LP002
    Associations

    News

    Trials
    Company:
    Lepu Med
    Drug class:
    PD-L1 inhibitor
    Related drugs:
    Associations

    News

    Trials
    3years
    A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms (clinicaltrials.gov)
    P1, N=94, Recruiting, Taizhou HoudeAoke Biomedical Co., Ltd.
    Clinical • New P1 trial
    |
    PD-L1 (Programmed death ligand 1)
    |
    PD-L1 expression
    |
    cisplatin • 5-fluorouracil • LP002
    3years
    A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma (clinicaltrials.gov)
    P1, N=63, Recruiting, Taizhou HoudeAoke Biomedical Co., Ltd.
    Clinical • New P1 trial
    |
    PD-L1 (Programmed death ligand 1)
    |
    Puyouheng (pucotenlimab) • LP002